Emmaus Life Sciences Inc (EMMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207604FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Emmaus Life Sciences Inc (EMMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Emmaus Life Sciences Inc(Emmaus) formerly known as MYnd Analytics Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychiatric EEG Evaluation Registry (PEER) Online, a cloud-based platform that enables physicians to exchange outcome data for patients referenced to neurophysiology data gathered using a standard electroencephalogram (EEG). Emmaus offers reference data and analytics tools for clinicians and researchers through the company’s psychiatric EEG evaluation registry or PEER online. It serves healthcare professionals across the US. Emmaus is headquartered in Mission Viejo, California, the US.

Emmaus Life Sciences Inc Key Recent Developments

Jan 27,2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25,2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31,2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08,2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02,2020: Emmaus Life Sciences provides operational updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Emmaus Life Sciences Inc – Key Facts
Emmaus Life Sciences Inc – Key Employees
Emmaus Life Sciences Inc – Key Employee Biographies
Emmaus Life Sciences Inc – Major Products and Services
Emmaus Life Sciences Inc – History
Emmaus Life Sciences Inc – Company Statement
Emmaus Life Sciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Emmaus Life Sciences Inc – Business Description
Emmaus Life Sciences Inc – Corporate Strategy
Emmaus Life Sciences Inc – SWOT Analysis
SWOT Analysis – Overview
Emmaus Life Sciences Inc – Strengths
Emmaus Life Sciences Inc – Weaknesses
Emmaus Life Sciences Inc – Opportunities
Emmaus Life Sciences Inc – Threats
Emmaus Life Sciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 27, 2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25, 2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31, 2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08, 2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02, 2020: Emmaus Life Sciences provides operational updates
Feb 05, 2020: Emmaus Life Sciences reports preliminary gross sales for the three months ended December 31, 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Emmaus Life Sciences Inc, Key Facts
Emmaus Life Sciences Inc, Key Employees
Emmaus Life Sciences Inc, Key Employee Biographies
Emmaus Life Sciences Inc, Major Products and Services
Emmaus Life Sciences Inc, History
Emmaus Life Sciences Inc, Subsidiaries
Emmaus Life Sciences Inc, Key Competitors
Emmaus Life Sciences Inc, Ratios based on current share price
Emmaus Life Sciences Inc, Annual Ratios
Emmaus Life Sciences Inc, Annual Ratios (Cont...1)
Emmaus Life Sciences Inc, Interim Ratios
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Emmaus Life Sciences Inc (EMMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Corium International Inc (CORI):企業の財務・戦略的SWOT分析
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Beckman Coulter Inc-医療機器分野:企業M&A・提携分析
    Summary Beckman Coulter Inc (Beckman) is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company’s products are used in a wide range of …
  • Synedgen Inc-医療機器分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Inter RAO UES (IRAO):電力:M&Aディール及び事業提携情報
    Summary Inter RAO UES (Inter RAO) is a vertically integrated energy utility. It has presence in the energy value chain, including electricity generation, transmission, sales, trading and engineering. The company generates power in thermal, hydro, and co-generation plants; and supplies that energy on …
  • Toyobo Co., Ltd.:企業の戦略・SWOT・財務分析
    Toyobo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyobo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Crescent Point Energy Corp. (CPG)-石油・ガス分野:企業M&A・提携分析
    Summary Crescent Point Energy Corp. (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and nat …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析
    Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tourism Holdings Limited:企業の戦略・SWOT・財務分析
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Stolt-Nielsen Ltd (SNI):企業の財務・戦略的SWOT分析
    Stolt-Nielsen Ltd (SNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Organogenesis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • China Synthetic Rubber Corp (2104):企業の財務・戦略的SWOT分析
    China Synthetic Rubber Corp (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cencosud SA:戦略・SWOT・企業財務分析
    Cencosud SA - Strategy, SWOT and Corporate Finance Report Summary Cencosud SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT. Bank Negara Indonesia (Persero) Tbk.:戦略・SWOT・企業財務分析
    PT. Bank Negara Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Negara Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Avalara Inc:企業のM&A・事業提携・投資動向
    Avalara Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avalara Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆